TRANSDERMAL PATCH DRUG DELIVERY SYSTEM MARKET ANALYSIS BY TYPE, APPLICATION, REGIONS AND COMPANIES FORECAST

  2024-11-27 |   Pages: 200+ |   Report ID: MD-R-2024-11-27-9241 |   Pharmaceuticals and Healthcare

Historical data: 2018 - 2023

Forecast period: 2024 - 2031

Quantitative units: Revenue in USD million and CAGR from 2024 to 2031

Report coverage: Revenue forecast, company ranking, competitive landscape, growth factors, and trends

Transdermal Patch Drug Delivery System Market

Image

1.1 SCOPE OF THE REPORT

1.2 MARKET SEGMENT ANALYSIS

1.3 REGULATORY SCENARIO BY REGION/COUNTRY

1.4 MARKET INVESTMENT SCENARIO STRATEGIC

1.5 MARKET ANALYSIS BY TYPE (USD MILLION)

1.6 MARKET ANALYSIS BY APPLICATION (USD MILLION)

2.1 DRIVER, RESTRAINT, CHALLENGE AND OPPORTUNITIES ANALYSIS

  2.1.1 MARKET DRIVER ANALYSIS

  2.1.2 MARKET RESTRAINT ANALYSIS

  2.1.3 MARKET OPPORTUNITY

  2.1.4 MARKET CHALLENGES

3.1 INDUSTRY TRENDS

  3.1.1 SWOT ANALYSIS

  3.1.2 PESTEL ANALYSIS

  3.1.3 PORTER’S FIVE FORCES ANALYSIS

3.2 POTENTIAL MARKET AND GROWTH POTENTIAL ANALYSIS

4.1 COVID-19 ANALYSIS

5.1 GLOBAL TRANSDERMAL PATCH DRUG DELIVERY SYSTEM MARKET, SALES AREA, TYPE

5.2 MERGERS & ACQUISITIONS, PARTNERSHIPS, PRODUCT LAUNCH, AND COLLABORATION IN GLOBAL TRANSDERMAL PATCH DRUG DELIVERY SYSTEM MARKET

7.1 GLOBAL TRANSDERMAL PATCH DRUG DELIVERY SYSTEM MARKET SIZE AND SHARE (2018-2031) (USD MILLION)

8.1 GLOBAL TRANSDERMAL PATCH DRUG DELIVERY SYSTEM MARKET SIZE AND SHARE BY TYPE (2018-2023) (USD MILLION)

8.2 GLOBAL TRANSDERMAL PATCH DRUG DELIVERY SYSTEM MARKET SIZE AND SHARE BY TYPE (2024-2031) (USD MILLION)

9.1 GLOBAL TRANSDERMAL PATCH DRUG DELIVERY SYSTEM MARKET SIZE AND SHARE BY APPLICATION (2018-2023) (USD MILLION)

9.2 GLOBAL TRANSDERMAL PATCH DRUG DELIVERY SYSTEM MARKET SIZE AND SHARE BY APPLICATION (2024-2031) (USD MILLION)

10.1 GLOBAL TRANSDERMAL PATCH DRUG DELIVERY SYSTEM MARKET SIZE AND SHARE BY REGION (2018-2023) (USD MILLION)

10.2 GLOBAL TRANSDERMAL PATCH DRUG DELIVERY SYSTEM MARKET SIZE AND SHARE BY REGION (2024-2031) (USD MILLION)

11.1 NORTH AMERICA TRANSDERMAL PATCH DRUG DELIVERY SYSTEM MARKET SIZE AND SHARE BY COUNTRY (2018-2023) (USD MILLION)

11.2 NORTH AMERICA TRANSDERMAL PATCH DRUG DELIVERY SYSTEM MARKET SIZE AND SHARE BY COUNTRY (2024-2031) (USD MILLION)

11.3 NORTH AMERICA TRANSDERMAL PATCH DRUG DELIVERY SYSTEM MARKET SIZE AND SHARE BY TYPE (2018-2023) (USD MILLION)

11.4 NORTH AMERICA TRANSDERMAL PATCH DRUG DELIVERY SYSTEM MARKET SIZE AND SHARE BY TYPE (2024-2031) (USD MILLION)

11.5 NORTH AMERICA TRANSDERMAL PATCH DRUG DELIVERY SYSTEM MARKET SIZE AND SHARE BY APPLICATION (2018-2023) (USD MILLION)

11.6 NORTH AMERICA TRANSDERMAL PATCH DRUG DELIVERY SYSTEM MARKET SIZE AND SHARE BY APPLICATION (2024-2031) (USD MILLION)

12.1 EUROPE TRANSDERMAL PATCH DRUG DELIVERY SYSTEM MARKET SIZE AND SHARE BY COUNTRY (2018-2023) (USD MILLION)

12.2 EUROPE TRANSDERMAL PATCH DRUG DELIVERY SYSTEM MARKET SIZE AND SHARE BY COUNTRY (2024-2031) (USD MILLION)

12.3 EUROPE TRANSDERMAL PATCH DRUG DELIVERY SYSTEM MARKET SIZE AND SHARE BY TYPE (2018-2023) (USD MILLION)

12.4 EUROPE TRANSDERMAL PATCH DRUG DELIVERY SYSTEM MARKET SIZE AND SHARE BY TYPE (2024-2031) (USD MILLION)

12.5 EUROPE TRANSDERMAL PATCH DRUG DELIVERY SYSTEM MARKET SIZE AND SHARE BY APPLICATION (2018-2023) (USD MILLION)

12.6 EUROPE TRANSDERMAL PATCH DRUG DELIVERY SYSTEM MARKET SIZE AND SHARE BY APPLICATION (2024-2031) (USD MILLION)

13.1 ASIA PACIFIC TRANSDERMAL PATCH DRUG DELIVERY SYSTEM MARKET SIZE AND SHARE BY COUNTRY (2018-2023) (USD MILLION)

13.2 ASIA PACIFIC TRANSDERMAL PATCH DRUG DELIVERY SYSTEM MARKET SIZE AND SHARE BY COUNTRY (2024-2031) (USD MILLION)

13.3 ASIA PACIFIC TRANSDERMAL PATCH DRUG DELIVERY SYSTEM MARKET SIZE AND SHARE BY TYPE (2018-2023) (USD MILLION)

13.4 ASIA PACIFIC TRANSDERMAL PATCH DRUG DELIVERY SYSTEM MARKET SIZE AND SHARE BY TYPE (2024-2031) (USD MILLION)

13.5 ASIA PACIFIC TRANSDERMAL PATCH DRUG DELIVERY SYSTEM MARKET SIZE AND SHARE BY APPLICATION (2018-2023) (USD MILLION)

13.6 ASIA PACIFIC TRANSDERMAL PATCH DRUG DELIVERY SYSTEM MARKET SIZE AND SHARE BY APPLICATION (2024-2031) (USD MILLION)

14.1 LATIN AMERICA TRANSDERMAL PATCH DRUG DELIVERY SYSTEM MARKET SIZE AND SHARE BY COUNTRY (2018-2023) (USD MILLION)/p>

14.2 LATIN AMERICA TRANSDERMAL PATCH DRUG DELIVERY SYSTEM MARKET SIZE AND SHARE BY COUNTRY (2024-2031) (USD MILLION)

14.3 LATIN AMERICA TRANSDERMAL PATCH DRUG DELIVERY SYSTEM MARKET SIZE AND SHARE BY TYPE (2018-2023) (USD MILLION)

14.4 LATIN AMERICA TRANSDERMAL PATCH DRUG DELIVERY SYSTEM MARKET SIZE AND SHARE BY TYPE (2024-2031) (USD MILLION)

14.5 LATIN AMERICA TRANSDERMAL PATCH DRUG DELIVERY SYSTEM MARKET SIZE AND SHARE BY APPLICATION (2018-2023) (USD MILLION)

14.6 LATIN AMERICA TRANSDERMAL PATCH DRUG DELIVERY SYSTEM MARKET SIZE AND SHARE BY APPLICATION (2024-2031) (USD MILLION)

15.1 MIDDLE EAST & AFRICA TRANSDERMAL PATCH DRUG DELIVERY SYSTEM MARKET SIZE AND SHARE BY COUNTRY (2018-2023) (USD MILLION)

15.2 MIDDLE EAST & AFRICA TRANSDERMAL PATCH DRUG DELIVERY SYSTEM MARKET SIZE AND SHARE BY COUNTRY (2024-2031) (USD MILLION)

15.3 MIDDLE EAST & AFRICA TRANSDERMAL PATCH DRUG DELIVERY SYSTEM MARKET SIZE AND SHARE BY TYPE (2018-2023) (USD MILLION)

15.4 MIDDLE EAST & AFRICA TRANSDERMAL PATCH DRUG DELIVERY SYSTEM MARKET SIZE AND SHARE BY TYPE (2024-2031) (USD MILLION)

15.5 MIDDLE EAST & AFRICA TRANSDERMAL PATCH DRUG DELIVERY SYSTEM MARKET SIZE AND SHARE BY APPLICATION (2018-2023) (USD MILLION)

15.6 MIDDLE EAST & AFRICA TRANSDERMAL PATCH DRUG DELIVERY SYSTEM MARKET SIZE AND SHARE BY APPLICATION (2024-2031)< (USD MILLION)/p>

16.1 Hisamitsu Pharmaceutical

  16.1.1 COMPANY DETAILS

  16.1.2 FINANCIALS (USD MILLION)

  16.1.3 PRODUCT SUMMARY

  16.1.4 RECENT DEVELOPMENTS

16.2 Novartis

16.3 ProSolus

16.4 Tapemark

16.5 Tesa Labtec

16.6 NITTO DENKO CORPORATION

16.7 Noven Pharmaceuticals

16.8 LTS Lohmann Therapie-Systeme

16.9 Medherant

16.10 Corium

16.11 Antares Pharma

16.12 Syntropharma

16.13 Teikoku Pharma

16.14 Mylan

16.15 Actavis

16.16 Mundipharma

16.17 Henan Lingrui Pharmaceutical

16.18 Changzhou Siyao

16.19 Rfl Pharmaceutical

18.1 METHODOLOGY

18.2 RESEARCH DATA SOURCE

  18.2.1 SECONDARY DATA

  18.2.2 KEY DATA FROM SECONDARY

  18.2.3 PRIMARY DATA

  18.2.4 KEY DATA FROM PRIMARY

  18.2.5 INDUSTRY INSIGHT FROM PROFESSIONAL LEADERS

  18.2.6 MARKET ESTIMATION

  18.2.7 MARKET ESTIMATION: TOP-DOWN AND BOTTOM-UP APPROACH

  18.2.8 LEGAL DISCLAIMER

Market Segments

By Type

Shunt Way
Intercellular Lipid Structure Pathway
Trans-cellular Pathway

By Application

Hospital
Clinic
Home Care

Companies

Hisamitsu Pharmaceutical
Novartis
ProSolus
Tapemark
Tesa Labtec
NITTO DENKO CORPORATION
Noven Pharmaceuticals
LTS Lohmann Therapie-Systeme
Medherant
Corium
Antares Pharma
Syntropharma
Teikoku Pharma
Mylan
Actavis
Mundipharma
Henan Lingrui Pharmaceutical
Changzhou Siyao
Rfl Pharmaceutical

Single User License  : 3900$
Corporate License    : 7800$
Enquiry Before Buying
Request For Customization
Speak To Analyst

BROWSE INDUSTRY

  1. Consumer Goods
  2. Healthcare
  3. Food & Beverage
  4. Heavy Industry
  5. Service Industries
  6. FMCG
  7. Life Sciences
  8. Technology & Media
  9. Machinery & Equipment

    WHY CHOOSE US

  •   PROACTIVE

    • We manage our resources 24/7 to identify issues and address them before they become problems.

  •   QUALITY & RELIABILITY

    • We are committed to providing reliable and highly accurate data with an excellent quality control system.

  •   GLOBAL OUTREACH

    • 6 Major regions and 40+ countries level analysis accomplished.

  •   COMPETITIVE PRICING

    • Our pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery.